Ethopabate

From WikiMD's WELLNESSPEDIA

Ethopabate

Chemical compound used as a coccidiostat in poultry

Ethopabate































Ethopabate is a chemical compound used primarily as a coccidiostat in poultry farming. It is often included in feed to prevent and control coccidiosis, a parasitic disease affecting the intestinal tracts of animals, particularly birds.

Mechanism of Action[edit]

Ethopabate works by inhibiting the growth and reproduction of Eimeria, the protozoan parasites responsible for coccidiosis. It interferes with the folic acid metabolism of the parasites, which is essential for their growth and replication.

Usage[edit]

Ethopabate is commonly used in combination with other coccidiostats such as amprolium to enhance its effectiveness. It is typically administered through the feed, ensuring that the poultry ingest the medication regularly to maintain effective levels in their system.

Safety and Regulation[edit]

The use of ethopabate is regulated in many countries to ensure the safety of the food supply. It is important to follow the recommended dosages and withdrawal periods before slaughter to prevent any residues in the meat.

Related Compounds[edit]

Ethopabate is part of a broader class of coccidiostats, which includes other compounds like monensin, salinomycin, and lasalocid. These compounds vary in their mechanisms of action and effectiveness against different species of Eimeria.

See Also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.